(Total Views: 633)
Posted On: 10/13/2020 8:55:43 AM
Post# of 153897
Quote:
To register leronlimab (PRO 140) for potential approval from the local Food and Drug Administration to treat patients with COVID-19 in the Philippines.
The key here is what will take to local FDA to approve LL.
Is it pending USA FDA approval ??? If yes, it only means a possible quick small market after approval
Would Philippines approve on their own based on existing/future data ??? This will mean name recognition, some small extra revenue and more "free" data with larger numbers.
Right now: just a positive PR showing an optimistic outlook for our possibilities in COVID
Hope we have some news this week regarding CD12.
(2)
(0)
